DBV Technologies

Medtech · Still private

Epicutaneous immunotherapy patch delivering allergen extracts through the skin to treat food allergies

Claim this profile

Follows are private to you and power your alerts

Updated · dbv-technologies.com

Sector
Medtech
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
12
7 pending · first 2018
Rank in peer group#176 of 1112

Capital timeline

No federal awards or Form D filings are on record for this company.

Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.

Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards

Founder? Add funding context

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#176 · top 16%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 12 granted of 19
Show all 19 patent records
  • Patch AssemblyFeb 10, 2026 · US D1,112,768Granted
  • Patch AssemblyFeb 10, 2026 · US D1,112,767Granted
  • Patch AssemblyMay 20, 2025 · US D1,076,110Granted
  • Patch AssemblyMay 20, 2025 · US D1,076,111Granted
  • Improved patches and methods for delivering an active substance to the skin using the sameDec 12, 2024 · Application 18702141Pending
  • Immunotherapeutic Method For Increasing Cashew Tolerance In A SubjectOct 17, 2024 · Application 18579691Pending
  • Patch AssemblyJan 23, 2024 · US D1,012,297Granted
  • Patch AssemblyJan 23, 2024 · US D1,012,296Granted
  • Patch AssemblySep 19, 2023 · US D,999,384Granted
  • Patch AssemblySep 19, 2023 · US D,999,385Granted
  • Compositions Of Food AllergensJan 5, 2021 · US 10,881,728Granted
  • Compositions Of Food AllergensMay 28, 2019 · US 10,300,133Granted
  • Allergen Desensitization MethodApr 30, 2019 · US 10,272,151Granted
  • Method Of VaccinationMar 7, 2019 · Application 16179851Pending
  • Allergen Desensitization MethodJul 17, 2018 · US 10,022,439Granted
  • Epicutaneous ImmunorebalancingNov 17, 2016 · Application 15111204Pending
  • Method Of Preventing AllergiesNov 10, 2016 · Application 15184933Pending
  • Method Of Preventing AllergiesDec 25, 2014 · Application 14373013Pending
  • Method Of VaccinationFeb 14, 2013 · Application 13651143Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .